I have been working with early-stage companies and entrepreneurs for over 20 years as both a business mentor and advisor to innovative start-ups. I am passionate about innovation and helping entrepreneurs to achieve success; my knowledge and perspective on fundraising and investment trends help businesses prepare to raise external funding. With strong links across the early-stage equity landscape I believe collaboration is vital to ensure innovation thrives.

25 years experience working with pharmaceutical, biotech, scientific instrument companies, and has held positions in marketing, business insights, product and project development. Currently he works to help seed and Series A stage companies to commercialise towards exit or market and obtain investment. These business development partnerships are typically very collaborative. Areas include the development of business strategy and tactics, investment, priorities for platform science and technology, route to market planning, instigating partnerships and specific projects such as grant applications. He has made 15+ angel investments and 45+ listed company investments in UK and international life science and impact companies. Works as a pro-bono mentor for accelerators.

"Josh is a Partner at Osney Capital, a value-add Venture Capital fund that invests in start-up and growth businesses in the Enterprise Technology sector, whilst supporting them to navigate their operational complexity as it evolves with their scale.

Josh has a background in Cyber Security and Financial Services, in Strategy, Growth and Front Office roles. Josh has an engineering degree from the University of Birmingham and an MBA from the University of Oxford."

An experienced Executive Director, Public Speaker, Consultant and Business Mentor, across multiple industries. Previous experience includes roles as CEO and Founder of an Oxford University Spin-out, Business Development Consultant, National Quality Manager, Material planner and Global Project Co-Ordinator.
With a demonstrated history of working in the Deep Tech, Sports Tech, Software Development, Business Consulting, Manufacturing, Automotive and Steel industries, within Australia, UK, Asia, and the US.
Core attributes are an entrepreneurial mindset with strong communication and leadership skills, and significant experience in strategic planning, early-stage venture capital fund raising, business process thinking, corporate governance and change management.

"I connect early-stage pharma R&D candidates with partners and other supporters.
I'm the CEO of Probatech, a consultancy founded to make sure that new healthcare products are developed to their full potential.

Over a varied career, I've found it unsettling that the world’s healthcare needs aren't met because potential solutions have been overlooked. Sometimes it's due to a lack of knowledge, sometimes a lack of resources.
But I believe it doesn't have to be this way and I'm now dedicated to helping startups and university teams drive their new drugs and vaccines to the next milestone before running out of time.

Having worked in pharmacy, in drug discovery research and as a consultant, I've gained a unique perspective on the challenges of bringing healthcare products to market. I've collaborated with biotech startups, Fortune 100 pharma companies and academic labs all over the world, and that's given me a better idea of the big picture.

Over the last 7 years, I’ve helped numerous life science organisations to understand how to get to their next developmental or commercial milestone without wasting time or money. Together with my team at Probatech, I'm using this experience to make vital connections between knowledge, people and resources to fast-track new healthcare products to the clinic.

Whether you're a startup with an exciting pipeline, or a larger organisation looking to support new ideas, please feel free to drop me a message.
I'd also love to hear from anyone who shares a passion for healthcare innovation, ecosystems and entrepreneurship in general."

Parkwalk Advisors invest in scientifically driven early stage companies in the UK. Emilie joined Parkwalk from Oxford University Innovation, where she worked both in the Investments Team and leading the Startup Incubator, managing over 80 projects and companies from inception to exit. She moved into technology transfer after 14 years as a research scientist, directing pioneering experiments in systems neuroscience in Oxford, Bordeaux and Hamburg. Emilie holds a PhD in Neuroscience from the University of Hamburg and an MBA from Warwick Business School, specialising in Strategy and Finance.

Paul has over 15 years of experience as a financial services and regulatory lawyer, including eight years as a partner leading the corporate team at offshore law firm Collas Crill LLP, building and nurturing high-performing teams. He built a diverse practice including advising on venture capital fund and joint venture structuring, mergers and acquisitions, banking & finance and financial services regulation. Paul has a MBA from the University of Oxford, an LLB from the University of New South Wales and a first class honours degree in Physiotherapy from Sydney University. Paul is currently working towards the first close of a venture capital firm he has founded with two fellow Oxonians.

Holding a degree in Quality Control of Medicines from the Federico II University of Naples and an MBA from Business School Lausanne, Valentina is a motivated and ambitious professional that has 13 years' experience in the pharma industry. Valentina has spent most of her career in Novartis in roles of increasing responsibility within quality assurance and manufacturing areas of drug development and commercial business units. After her MBA she decided to joined several “start-up like” companies. Now focused on driving and leading quality for a growing international cosmetic brand. She is positive, creative and inspiring with the passion for continuous improvement and problem solving. Traveler. Painter. Art and books lover.

"As a Chartered (UK) and European Patent Attorney, Matthew advises a wide range of clients in high tech fields, with particular expertise in computing and medical devices. He has been active in protecting innovations within the fields of medical devices, machine learning, digital healthcare and telecommunications. Matthew is also a Registered European Design Attorney, with experience advising clients on filing design registrations in the UK and Europe.

Matthew has been an active supporter of the ImagineIF! competition, acting as a mentor and advisor to applicants since 2016. "

David has a background in biochemistry, immunology and molecular biology with a PhD from Imperial College, London and three years of post-doctoral experience. David has worked in the pharmaceutical industry for over 20 years. He worked in big pharma at AstraZeneca for more than 17 years in a wide variety of R&D roles both in the UK and the US. Whilst at AstraZeneca he was heavily involved in developing the use of informatics and systems biology to support the development of new medicines. David joined Blueberry Therapeutics as Chief Scientific Officer at the start of 2014. In this role, he is responsible for leading the research activities of the business which are focused on developing new treatments for serious infectious diseases. The first of these treatments is currently in Phase 2 clinical testing.

"Aldo is working in line with Business’ CEO and CTO’s, making decisions and reaching successful conclusions with regard to digital technologies.
He possesses extensive client facing experience in B2B and B2C and continues to be a confident manager across different countries for large web development teams, as well as for outsourcing companies. Aldo demonstrates natural ability in organising teams, client and projects, making the process run perfectly for large organisations, without the hassle of technicalities.
He has an ongoing long-standing experience within helping startups as a mentor & coach"

Creating sustainable and supportive ecosystems for entrepreneurs is both Daniel's personal and professional passion. Currently, he leads the innovation management process in Northern Barcelona, particularly, in Germans Trias i Pujol Hospital, one of the major Catalan hospitals providing high technology and complex healthcare to over 1.200.000 patients. Working in the scope of the Gerencia Territorial Metropolitana Nord, his main task is to identify, nurture and grow innovative projects and initiatives arising from healthcare professionals and activities.

Daniel has extensive experience in business development, innovation, research and project management, marketing, communication, start-ups and STEM ecosystem development. In this sense, he founded Innovation Forum Manchester, where he was President, and led the global marketing, communication and operations strategies for a number of years. He also occasionally evaluates EIT Health projects and serves as a mentor in the MCN network.

Interested in new technologies and in entrepreneurship through leadership and innovation, he has many years of experience working and leading international teams: he was Vice-chairman of the Young European Biotechnology Network, where he was also Chief Communication Officer and an Executive Board member. Daniel has participated in the organisation of many scientific and outreach meetings in the UK, Germany and Spain. Overseeing and supporting more than 15 different projects in 7 different countries, he has played a key role in the strategic development, innovation and talent management in a number of companies.

He has an extensive list of scientific publications from his time as an academic in Manchester (United Kingdom), where I worked in cardiovascular research, platelet and endothelial function in the context of inflammation.

Daniel founded Biorelate during a PhD in computational biology at the University of Manchester, after supporting the successful identification of drug repurposing opportunities with Pfizer. Daniel’s focus remains on growing Biorelate into a world leading enterprise, helping pioneering companies in their mission to develop life-saving innovations.

"Technology Sales and Strategic Marketing
professional with extensive global experience within all facets of business development and operational management across oil and energy industry.
Solid record of streamlining and overseeing optimal efficiency of organisational functions to ensure attainment of maximised productivity and excess revenue streams. Demonstrated expertise in directing multiple major projects/assignments at a time, product launches, and Strategic Action Plan (STRAP) implementations from inception to completion within timely and budgetary constraints.

Proficient in developing and initiating robust strategic measures and technical-economic models to assess the viability of new offerings."

I am a seasoned technology executive with a strong commercial acumen and expertise in building, scaling and turning around global technology/technology enabled businesses. Over the last decade I have extensively worked with disruptive technologies like AI, machine learning and big data to build new products and business models. I am well versed in enterprise sales methodologies, senior stakeholder management and complex deal negotiations and currently work with a variety of startups as growth hacker. I am also in the process of setting up a tech focused VC fund and help companies raise funding end-to-end mostly up to Series A stage.

Lastly I am a trusted board advisor to various startups in fintech/AI space based in the UK, Africa and India and lead/contribute to multiple accelerators and startup ecosystems.

Melissa joined Closed Loop Medicine as Chief Financial Officer in July 2020 and helps to lead the company on financial and strategic matters. Building on a background in law, Melissa qualified as accountant in 2004 and has worked in a number of finance roles within organisations including both in public practice and a FTSE 250 business. Melissa has spent 13 years working in life sciences, joining most recently from Summit Therapeutics, a NASDAQ listed UK biotech where she helped the company develop from early stage discovery through to preparing for commercial launch. With experience in corporate and commercial transactions, Melissa co-led the acquisition of an early stage company as part of the development pipeline strategy at Summit and was also actively involved in raising over £100m through UK and US private and public financings and helping to secure ~$80m in non-dilutive funding.

Melissa also has an Executive MBA from University of Oxford, where she had a particular focus on corporate finance and strategic leadership.

Michael is qualified as a solicitor (in the jurisdictions of both England/Wales and the Republic of Ireland) and is also registered as a UK and European Trade Mark and Design attorney, specialising in advice to brand owners. He advises on all aspects of trade mark protection and registration, including portfolio management, clearance searching, trade mark prosecution, opposition, cancellation, revocation, licensing, assignment, infringement and the law of unregistered trade marks/passing-off. He also advises on the filing of registered designs and on copyright infringement.

Sue Rees has been supporting CEO’s and Founders for the past 25 years, enabling them to attract the leadership team to achieve their global ambitions. She is an expert C-Suite executive search specialist working within Pharma, Biotech, Life science and Technology.

With a wealth of experience she is passionate about connecting people and with a wide network she is more than happy to recommend support to other areas of business. Very much a people person Sue has mentored a wide variety of entrepreneurs in developing their business plans and also advised on their personal portfolio. Sue is passionate about engaging businesses across a diverse range of people and thrives in providing knowledge, experience and opportunities.

Focused on building partnerships and collaborations worldwide, I've built successful B2B relationships with broadcasters, telecoms / cable operators, enterprises and SMBs, and have developed, launched and delivered profitable and innovative digital technology and new media solutions and services.

Working with and mentoring early stage media technology companies across all sectors, including the converged market of the internet, TV, social media and gaming, helping them complete their solutions and services, build commercially viable business models (and effective teams), and take them to market.
Also working to establish an business environment in Oxfordshire that encourages and supports innovation and entrepreneurship across industry sectors.

Specialties:
• Networking to build and develop strategic partnerships and alliances
• Creation and implementation of innovative business strategies and marketing programs
• Understanding of technical features of products and services, to translate them into tangible customer benefits, and to steer future product development.
• Experienced in channel marketing, product marketing, market communications, business development and sales management

Laura is a Partner in Keltie’s Life Science and Chemistry team. She has a broad academic background in biochemistry and specialises in patent matters relating to biotechnology, precision medicine, immunology, gene therapy, pharmaceuticals, medical devices, stem cells and regenerative medicine, diagnostics, medicinal chemistry, and chemical technology. Laura has a keen interest in precision medicine and medical devices and enjoys working with early stage companies, spinouts and SMEs, and providing strategic and practical advice and support.

David is a Chartered Trade Mark Attorney. He specialises in the prosecution of UK and EU trade marks, trade mark audits, clearance searches and contentious matters such as trade mark opposition proceedings, infringement matters, revocation and invalidity actions. David works with clients large and small across a very broad range of sectors, and particularly enjoys working with start-up clients setting out on their journey.

As a member of Keltie’s IT, Telecoms and Electronics team, Samantha specialises in handling software and computer-implemented inventions, and particularly enjoys working with clients applying emerging ‘next generation’ digital technologies (such as artificial intelligence, machine learning and 5G) across a variety of technical fields. She is especially interested in the application and cross-over of such technologies in the field of medical technologies. In her time at Keltie, Samantha has also worked with a variety of start-up clients to identify and formulate strategies for protecting various aspects of their Intellectual Property.

Gary is an IT Strategy consultant, Cyber Security solutions designer & entrepreneur, helping clients from various industries to select and deploy the best cloud applications for their businesses.

Gary started his career working with ICL & Fujitsu (1985 -2006) in many different roles including Procurement, IT Operations, IT Project Management and IT Sales & General Management. Gary handled multiple projects and notably won and managed the project to manufacture the terminals for the UK National Lottery in 1994.

Gary then proceeded to start Greenlight Computers in 2006 as a "Single point of IT services" to provide services including IT outsourcing, digital marketing, cloud solutions, cyber security & IT support. He has since overseen the establishment of 3 other start-ups and has occupied non-executive roles in 10 companies.

Dom Raban is the co-founder and CEO of Xploro, a digital therapeutics (DTx) platform that uses augmented reality, artificial intelligence and games to reduce anxiety for young patients going to hospital.

Dom established Xploro in 2016 after his daughter had recovered from cancer treatment and he realised the importance of providing patients with information about their treatment – something that was lacking in his daughter's experience. Now the award-winning platform is in use in hospitals in the UK, Europe, Asia and Australia. Recently Xploro scored 88% on Orcha, the world's leading healthcare app review platform, making Xploro the highest scoring app on the platform for the search terms 'cancer', 'children' and 'stress and anxiety'.

Dom has been creating 'stuff' for over 40 years, from punk fanzines in the 1970s to content for emerging technology platforms now. He's been in the digital space since the start, building his first website in 1995 and his first 3D virtual environment in 1996. He is also Chair of Corporation Pop, a digital innovation agency that specialises in a user-centred design approach to develop apps, games and software.

Mike is an amazing combination – he has deep expertise & skills from his background in Venture Capital. He absolutely understands business and how to build it based on solid fundamentals. Mike also has a razor sharp mind and is very direct and to the point. Melinda likes to tease him that he is the “Dr. Phil” of business – he’s going to tell you like he sees it, whether it’s easy to hear or not!” - Melinda Phillips, ZümiFi

For over ten years, we have been working with entrepreneurs and businesses to support and grow their businesses. We recognize that it takes much more than financial support to get a company off the ground, thus we provide assistance in every aspect along the way allowing business owners to take their businesses to the next level.

Our executive team offers insight, experience, and a hands-on approach to cultivate early stage concepts, products, and services into commercially successful business opportunities.

We work with a full range of clients from Berlin Start-Ups in Silicon Allee to international firms seeking to do business in either Berlin or San Francisco.

With over 15 years of international senior management experience in strategic and operational risk management, Mustafa now focuses on impact business and entrepreneurship. In his most recent project he supported designing an impact investment fund for a social enterprise incubator and accelerator aiming to provide patient capital to underrepresented founders in London. Mustafa holds an MBA from ESCP Business School and is based between London and Utrecht.

Small company CEO.
Business advisor, mentor, coach.
Areas of expertise: Medtech-, bioscience- and technology-based sectors.
Previously in a variety of national and global sales, marketing
and business roles in AstraZeneca

Dr Andy Round, PhD in Biochemistry and Directors at Praetura Ventures. I am a specialist healthcare investor having invested in life science companies for the past 15 years. I have invested from a range of different sources from EIS and VCT to balance sheet and public private funds. Over the past 15 years I have invested in both early stage and later stage companies across the country and across all of healthcare from therapeutics and diagnostics to medical devices.

Mr. Roy Fung is the Managing Director of Hexon Group, CEO of Hexon Green Capital Ltd., Founder, and Chairman of the Dialogue-in-the-Dark (HK) Foundation. Roy is a strategic thinker and successful entrepreneur; he understands the key success factors and winning strategies that contribute to a business quantum leap. Roy brings more than 20 years of experience in Asia Pacific business and HR consulting; he has completed over 160 business consulting and M&A projects for more than 100 large local and multinational organizations in Banking, Finance and Retail in Greater China.

Dr Joanne Mason is the Chief Scientific Officer at Yourgene Health, leading the scientific strategy across this global organisation who focus on reproductive health and precision medicine using non-invasive technologies. Joanne has been a champion of modernising diagnostics with the use of genomic technologies having previously held positions as VP Biodiscovery with Cambridge Epigenetix where she led the development of clinical epigenomic technologies particularly in the area of early cancer diagnostics, the Director of Sequencing and Sample Acquisition for Genomics England, where she managed the delivery of samples and whole genome sequencing for the 100,000 Genomes Project.

A multi-awarded Creative Director and serial entrepreneur, David Orlic’s work has been featured as cover stories in the New York Times and highlighted by the Obama Foundation. Today, he is the co-founder and CEO of Anyone – an audio app for five-minute conversations, named one of Europe's Hottest Startups in WIRED.

Flavia is the CEO and founder of iBreve and has over 12 years of experience working in health innovations & technology. Prior to her entrepreneurial journey she worked at Google as a Legal Operations Specialist for Germany & Product Lead for Google Image Search. She was the winner of Ireland's Best Young Entrepreneur for Dublin City and named by Forbes among the top 50 Women-Led Startups Disrupting HealthTech. She is holding a Master's Degree in Business Administration with a focus on marketing, international trade and psychology.
In the past she has mentored early stage startups at the Dogpatch Labs startup hub in Dublin and within the international D-Health fellowship innovation program. She also has experience from working as an innovation evaluator for various organisations like EIT Health & regularly gives entrepreneurial talks at universities like the EADA business school and the IQS university.

I am an Associate Researcher working in prof. Dotto laboratory since September 2017. I graduated at the University of Turin in Molecular Biotechnology in 2011 and obtained my PhD in Molecular Medicine at the University of Turin in 2016.
I have extensive experience in academical research especially skin regenerative medicine and skin cancer. I took part in several project from mechanistic studies to population studies involving both human and mouse samples. I have experience in mentoring master and PhD students in their lab activities and projects and I redacted several grants, papers and applications for ethical permits (for the use of both animal models or human samples).
As part of the new Cancer Prevention Institute headed by prof. Dotto in CHUV I also started collaborating in an Innosuisse project together with a local Start-up.

Nicoletta Loggia is a proven, global, development leader in the biopharmaceutical industry with extensive strategic and hands-on experience with recombinant protein therapeutics, cell and gene therapies, small molecules, devices and combination products from concept to commercialisation, and in leading multidisciplinary global teams to deliver innovative products that improve patient’s lives and building sustainable, strong and fit for the future capabilities.

She currently serves as the Chief Technical Officer at Orchard Therapeutics. Previously, she acted as the Global Head Cell & Gene Development at Novartis leading multidisciplinary international teams responsible for the end-to-end technical development of cell and gene therapies (Stem and CART and AAV, LV) and focused on meeting unmet medical needs of patients with rare diseases.

A tested leader during times of both growth and downsizing, Dr Loggia’s focus on integrity, leadership, operational excellence, and risk-based decision making has enabled her to continually increase scope and influence throughout her career.

A graduate of the University of Pavia (Italy) with a Master in Chemistry and Pharmaceutical Technologies and a PhD in Pharmaceutical Technologies, Dr Loggia brings technical expertise and a global mindset to her endeavours. As she continues on a path of lifetime learning, she has completed a Certificate in Law and Society from the University of Canterbury (UK) and, most recently, a Board of Directors Academy program at EFPL Lausanne (Switzerland).
She is a registered Member of the Royal Pharmaceutical Society of Great Britain and of the Italian Pharmaceutical Society (Ordine di Milano) and is an accredited Board of Director for Start-ups by the EPFL Board Academy Lausanne (Switzerland).

I have started my career in science, with a PhD in Chemical Engineering. In 2018, while I was developing the project, I co-founded Aortyx. During all these years, I have designed the product and set up the scientific team, together with all the aspects that imply founding a start-up.

Healthcare professional with 8 years in life sciences and broad experience from product development to launch across pharmaceuticals, medtech / digital health, consumer health / goods, gained via a mix of industry, consulting and research.

I hold a Ph.D. in Chemistry from Oxford University and a MSc and BSc in Chemistry from University of Trieste and Naples respectively.

In addition, I completed a Master in Healthcare Management, Economics and Policy from SDA Bocconi in Milano (IT).

DAVID BLÁNQUEZ CAUREL, CEO, co-Founder and Project leader. Engineer.
Specialist in artificial vision and robotics, machine construction and industrial projects.
Own engineering company for 12 years; Electrical engineering chief for 4 years.

David holds a bachelor’s degree in Automation and Industrial Computing Engineering from the University of Girona. He also formed as a Manager at EADA Business School. In 1999 he founded Sisvision S.L., an engineering company dedicated to build and commercialize systems and machinery for artificial vision inspection, automation and robotics, mainly to industrial manufacturers, automotive, plastic industries and food and beverage sector. After 12 years he left the company and work for Ames CMA SA. during the following 4 years as chief engineer and interplant chief for NDT quality systems.

At mjn-neuro David is dedicated to technology development, product development, clinical trials with real patients, relations with patients´ associations, medical collaborations, regulatory and intellectual protection for the device. Project management, public funding and private investment, for epilepsy and new projects as Alzheimer is also under his tasks.

Medical Doctor specialised in medical imaging and image-guided intervention, and CMO of a MedTech startup developing image analysis software based on AI. Sharing time between clinical practice and entrepreneurial ventures. Prior experience in strategy consulting, investment and corporate venturing with a focus on innovation in healthcare and LifeSciences. Prior researcher and principal investigator.

I am currently Chairman at Novel Technologies Holdings Limited, Chairman of The Electrospinning Company Limited, Non-Executive Director of Pneumowave Limited, Non-Executive Director of Cytomos Limited and Visiting Professor (Technology Entrepreneurship - Biomedical Engineering) at the University of Glasgow. Previously CEO of two public Life Science companies, including founding CEO of Collagen Solutions plc, I have 20 years’ experience in the areas of Regenerative Medicine, Medical Devices and Biomaterials. I am a graduate of the University of Strathclyde, with a BSc. in Applied Microbiology (1st), Ph.D. in Bioprocessing and Fermentation Technology and an MBA.

University Degree in Life Science with international research experience in molecular microbiology; Post Degree in Health Economics/HTA and Market Access at SDA Bocconi School of Management;

8 years of working experience in Pharma Companies in Asthma, BPCO, Oncology (CRC, AML, MDS), Nephrology, Cardiovascular, Diabetes, Antibiotics, Onco-dermatology (CTCL, Actinic Keratosis), Acne and Rosacea. I worked for the Italian, CEE, and Global markets.

Thanks to my experience I have learned how to build the Pricing and Access launch strategy of a new product, in a matrix structure, cross-functional and multi-cultural teams, and the ability to communicate Scientific and Pharmacoeconomics results with appropriate and simple language and translate the strategy to actions.

Simon Hall runs his own business communication agency, Creative Warehouse, and is a journalist, author, business coach and university tutor.

He teaches communications, media, business and public relations skills at the University of Cambridge, for government departments, and companies.

Simon has a series of books on business communication – from public speaking, to writing blogs, to securing media coverage - published, along with eight novels.

Previously, he was a broadcaster for 20 years, mostly as a BBC Television, Radio and Online News Correspondent, specialising in business and economics.

He is a columnist for Business Digest and StartUps magazines, has contributed articles to a range of newspapers, written BBC radio comedy, short stories, plays, and even a pantomime (oh, yes he has!)

You might also be interested to know that in his time Simon (i) once played football for the same manager who coached the legendary Pele (although to far less impressive effect), (ii) discovered the memorial to the late Poet Laureate Ted Hughes on Dartmoor after a long quest (iii) was writer in residence on the bus services around Cambridge, and (iv) in possibly his proudest achievement, once got 10/10 at identifying freshwater fish in a pub quiz picture round.

Telecomm Engineer and Market Research professional with ~20 years expertise in Commercial Effectiveness, Business Analysis, Marketing, Omnichannel Customer Engagement and Business Development & Alliance Management.
Corporate Director used to lead transformative change in pharma organizations driving results through multidisciplinary teams at HQ and Local Affiliate level. Additional experience in other industries such as Clinical Nutrition (Nestlé) , Retail (Nestlé), People Transportation (Barcelona TMB) , Energy (Gas Natural), Consultancy (IBM) and Telecomm (Orange).

Hele is the Head of Business Development at Bactobio Ltd - a young London-based biotechnology company aiming to uncover novel solutions from unexplored soil bacteria. Bactobio's first targets tackle some of humanity's greatest challenges: discovering new antibiotics to combat the growing antimicrobial resistance crisis and new biofungicides to help protect the future global food supply.

Working with the team since an early stage, she wears many hats and has seen the company grow more than 3x since joining. Her responsibilities range across sourcing and securing dilutive and non-dilutive funding, corporate governance, investor relations, marketing, business model design, recruiting, internal operations and IP strategy coordination.

Prior to Bactobio, Hele worked as a management consultant at Oliver Wyman and completed a PhD in Chromosome and Developmental Biology at the University of Oxford.

Seasoned market access expert at corporate level (biotech/medtech). Entrepreneur and advisor in life sciences dealing with technology from Academia. Legal backgroung complemented with an Exec Master in Finance and and one in Health Tech Assessment.

Robert has a solid marketing & sales, project and business development expertise, building and empowering expert teams (10 to 100 FTEs) and developing innovative strategies. His track record of profit and loss responsibilities includes delivering sales and marketing targets ranging from €35 million to €1.3 billion. Previous companies include Schering Plough, Sanofi, Serono, and Merck Serono. Robert’s academic background includes a Master of molecular biology (University of Geneva) and 5 years of research in neuroscience (University of Lausanne), as well as varied teaching experiences. He has worked in several therapy areas, including oncology, neurology, rare & orphan diseases. Robert has successful start-up experiences (Anesta exit, plus co-founding 3 start-ups).

Passionate to bring Healthcare Innovation to people’s life.
Visionary leader with 20+ years’ experience in international pharma/biotech and management consultancy;
Therapeutic areas: oncology; neuroscience, Alzheimer’s; cardiometabolic
Functions: digital transformation, customer experience, commercial effectiveness, marketing, market access
Digital Health start-up mentor
Care for people, deep listener, entrepreneurial spirit, focus on outcomes

Thomas holds a PhD in Managerial Science and Applied Economics from University of Pennsylvania, an MA from University of Pennsylvania and University College Dublin and a BA Science from Duale Hochschule Baden-Wuertemberg. Prior to pursuing an academic career, he was a financial analyst and project manager at IBM and JP Morgan. In those functions, he was involved in several worldwide projects in corporate finance and business development.
Thomas' research interests lie at the intersection of strategic entrepreneurship and innovation. He focuses on how established and emerging firms manage technological change and the strategies firms pursue to develop and commercialize new technologies. His work has been published in Academy of Management Journal, the Journal of Management Studies, Research Policy, Nature Biotechnology, the European Management Review, and Academy of Management Best Paper Proceedings (2013, 2014), and has been presented at several international conferences.
In 2013, his dissertation-related work was among the finalists of the Druid Young Scholar Paper award and the Technology and Innovation Management (TIM) division best paper at Academy of Management. He won the best student paper prize within the TIM division at AoM 2013.

Dr. Ioannis (Jiannis) Ragoussis is the Head of Genome Sciences at the McGill Genome Center and Professor in Human Genetics, at the Department of Human Genetics and Department of Bioengineering, McGill University.
He has a long-standing career of 35 years in genomics, since the start of his PhD in Biochemistry with Immunology and Genetics at the University of Tübingen, Germany. He has introduced new genomics technologies for gene identification and mapping at Guy’s Hospital in London as Lecturer and Reader, introduced high-throughput genotyping technologies at Oxford University as Head of Genomics, where he also established Next Generation Sequencing. He has developed expertise and experience stretching over a wide spectrum of next generation sequencing applications. Since he moved to McGill University in 2013, he has established genomics facilities, introduced for the first time in Québec and developed single cell genomics, long read sequencing in form of Nanopore and PacBio Sequel, as well as Hi-C approaches for de novo genome sequencing. He is also leading the McGill Genome Centre’s Advanced Genomic Technologies laboratory working on single cell genomic approaches in cancer and neurological diseases, applying a number of protocols for single nuclei and single cell based transcriptomic analysis. He is leading virus genomics and sequencing in the CIHR funded Network CoVaRR-Net and a member of the CanCOGeN virus and host sequencing consortium. He has experience in working with national and international consortiums, while leading several Canada Foundation for Innovation funded projects. He has authored or co-authored over 250 publications in the field of genomics.

Mayank is International Sales and Technology Leader with hands-on expertise in Big Data, IoT, Analytics, AI (Computer Vision) and 5g/Edge Computing. A Visionary and strategist with over 20 years of experience working across different Geographies - EMEA, Sub Saharan Africa, Asia and North America in Technology leadership, Delivery, Pre Sales and Sales roles.

5 years of experience in helping start-ups translate research into viable commercial propositions. Innovation and BD as my primary job, consulting for VCs as my second job. Wide network of VCs/angels.

An ecosystem builder with an entrepreneurial mindset. Maria is an established leader in creating and maintaining communities of start-ups, tech entrepreneurs, investors, and subject-matter experts on global issues. She is passionate about science and technology-based start-ups, game-changing innovations, and purpose-driven businesses that focus on world-scale challenges. She has demonstrated the ability to translate among different actors in the system; scientists and business people, entrepreneurs and investors, visionaries and doers, in order to deliver impactful projects.
Maria has designed and led multiple successful initiatives supporting entrepreneurs from the idea stage to SME growth strategy. She is deeply experienced in developing personalized support networks around ambitious entrepreneurs and in building multi-disciplinary teams. Her expertise and interest lay in the areas of start-up development, tech commercialization, business strategy, innovation, venture funding, and SME growth.

Aline Noizet is a connector by heart! Shas strong international experience working with startups, helping them scale-up and connect with corporate companies.

Aline currently serves as social network manager at Nina capital and eHealth Enthusiast at Startup Colors. She also works with corporates and individual startups to support them in whatever they need to succeed.

Her past roles include:
> Program manager for Bayer G4A (Grants4Apps) Accelerator programs in Barcelona, United States and Berlin
> Business Development Director Europe for Health 2.0, a company showcasing the latest innovations in healthcare
> Partner of eHealth Hub, an EU project, supporting digital health SMEs
> Chief International Officer at Barcelona Health Hub as well as Executive Producer of all the online and offline events

She also co-founded Digital Health Innovators Barcelona, a local community bringing together the actors of the digital health ecosystem and she has been collaborating with institutions like Frontiers Health, EIT Health, GIANT, SXSW, Medica and Vision Health Pioneers.

Founder and director of Studio Mango a Netherlands based industrial design form with 20 design engineers. Personal background in mechanical engineering and industrial design. Working for many start-ups, scaleups, SME's and corporates in the development of their hardware products. Especially in the fields of: medical, mobility, IoT and sustainability.

As a member of Keltie's Life Science and Chemistry team, Paul supports a range of clients from start-ups to multinationals. He has developed expertise with clients active in the fields of industrial biotechnology, nutrition, biological modelling, plant sciences, medical devices, fuels and catalysts. Paul has a particular interest in precision medicine, and also has experience with targeted and localised therapies using a variety of therapeutic agent types.

I specialise in the commercialisation of science and technology. In particular, advising on licensing deals, collaborations and R&D projects, distribution and manufacturing, commercial and regulatory aspects of M&A, VC investments and IPOs.

Providing communication, design and digital media marketing for life sciences and biotech enterprises.

We are a small, agile communications consulting firm that can help scientists, engineers and other specialists create clear and compelling stories for research journals, funding applications and high-stakes presentations to colleagues and stakeholders.

We are ourselves researchers who left the laboratory bench to pursue “alternative” careers in teaching, publishing, writing, policy analysis, nonprofit management and entrepreneurship.

We have developed a rich perspective on how scientists can engage most effectively with one another and with external audiences.

I am a recommended intellectual property and commercial lawyer with a global profile and I head up the Marks & Clerk XR team. I have been advising technology companies since 1997. I am based in Cambridge, Europe's largest technology cluster, and London but also service clients nationally and worldwide. Most significantly, I play a leading role in the firm's Nordic practice, especially with regard to Norway and Finland. My clients include entrepreneurs, universities, charities and companies in the life science, electronics, software and entertainment sectors.